AI Assistant
Blog
Pricing
Log In
Sign Up
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
